Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06993675 |
Title | Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE) (ROTATE) |
Acronym | ROTATE |
Recruitment | Not yet recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Noffar Bar |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |